<DOC>
	<DOCNO>NCT01667614</DOCNO>
	<brief_summary>The detrimental effect aldostrone adequately arrest use angiotensin convert enzyme ( ACE ) , angiotensin II receptor blocker ( ARB ) combination . Recent evidence provide robust evidence aldostrone escape play important role regard . It believe aldostrone escape occur quite commonly report indicate prevalence rate high 22 % ARBs 40 % ACE inhibitor . In trial patient diabetes hypertension show treatment aldostrone escape spironolactone 25 mg daily three month significantly reduce proteinuria . A number trial similarly observe addition spironolactone ACE inhibitor base regimen provide additional benefit proteinuria reduction , blood pressure control , prevention glomerular filtration rate ( GFR ) decline . Most available trial regard short duration ( e.g . three month ) , add spironolactone ACE ACE+ARB base regimen ( so-called triple blockade ) . Currently , evidence evaluate efficacy combine ARB+spironolactone regimen compare conventional double RAS blockade ( i.e . ACE+ARB ) lacking . Hence , randomize open label trial initiate determine effect addition spironolactone 25 mg daily losartan period 18 month .</brief_summary>
	<brief_title>Effects Spironolactone Combination Therapy Proteinuria , Kidney Function , Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>type 2 diabetes patient diabetic nephropathy range micro macroalbuminuria treatment combination enalapril losartan one year history nonadherence prescribe medication assess prescribe physician baseline potassium &gt; 5.5 meq/L chronic kidney disease stag 4 5 history evidence nondiabetic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>